Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Up-frameshift protein 1 (UPF1) is a highly conserved ATP-dependent RNA helicase and ATPase that plays a central role in the nonsense-mediated mRNA decay (NMD) pathway, a fundamental mRNA surveillance mechanism that degrades messenger RNAs containing premature stop codons and regulates the abundance of many normal mRNAs[2][4]. UPF1 operates as a monomeric helicase with high processivity on nucleic acids; it translocates along and unwinds RNA secondary structures using energy from ATP hydrolysis[1][2][3][4]. The protein has a structurally unique helicase core with two RecA-like domains and subdomains critical for RNA binding and regulation[1][2]. UPF1 function is dynamically regulated—its ATPase activity is autoinhibited until activated by interacting proteins such as UPF2, which is essential for efficient NMD[3]. Mutations in UPF1 can disrupt NMD and are implicated in several human diseases, particularly cancer and neurodegeneration[2][3][4]. While there are no approved drugs directly targeting UPF1, its pivotal role in RNA surveillance makes it an attractive candidate for future therapeutic modulation, albeit with significant safety considerations due to the essential nature of NMD in cell homeostasis.
Molecules (not yet specific drugs) targeting UPF1 could modulate NMD through inhibition or activation of its helicase or ATPase activity, affecting mRNA decay.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Up-frameshift protein 1 (UPF1).